The first example of an RNA urea synthase: Selection through the enzyme active site of human neutrophile elastase

ChemBioChem

Volumn 4, Issue 7, 2003, Pages 651-654

  Nieuwlandt, Dan ^a   West, Madeline ^a   Cheng, Xiaoqin ^a   Kirshenheuter, Gary ^a   Eaton, Bruce E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Diastereoselectivity; Enzyme catalysis; Peptides; RNA; Stereoselection

Indexed keywords

ELASTASE; RNA UREA SYNTHASE; SERINE PROTEASE TRIPEPTIDE PHOSPHONATE INHIBITOR; SERINE PROTEINASE INHIBITOR; SUICIDE SUBSTRATE; SYNTHETASE; TRIPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CATALYST; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SUBSTRATE; PRIORITY JOURNAL; RNA SEQUENCE; STEREOCHEMISTRY;

BINDING SITES; BINDING, COMPETITIVE; HUMANS; KINETICS; LEUKOCYTE ELASTASE; OLIGOPEPTIDES; RNA, CATALYTIC; STEREOISOMERISM; SUBSTRATE SPECIFICITY; UREA;

EID: 0041305988     PISSN: 14394227     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbic.200300610     Document Type: Article

References (43)

1. a) S. Altman, Prix Nobel 1990, 140-160;
2. b) T. R. Cech, Prix Nobel 1990, 165-188.
3. a) T. R. Cech, D. Herschlag, Nucleic Acids Mol. Biol. 1996, 10, 1-17;
4. b) R. B. Van Atta, S. M. Hecht, Adv. Inorg. Biochem. 1994, 9, 1-40;
5. c) G. J. Narlikar, D. Herschlag, Annu. Rev. Biochem. 1997, 66, 19-59;
6. d) G. F. Joyce, Curr. Biol. 1996, 6, 965-967;
7. e) N. Lee, Y. Bessho, K. Wei, J. W. Szostak, H. Suga, Nat. Struct. Biol. 2000, 7, 28-33;
8. f) E. A. Doherty, J. A. Doudna, Annu. Rev. Biochem. 2000, 69, 598-615;
9. g) J. A. Doudna, T. R. Cech Nature 2002, 418, 222-228.
10. a) H. F. Noller, Annu. Rev. Biochem. 1991, 60, 191-227;
11. b) H. F. Noller, V. Hoffarth, L. Zimniak Science 1992, 256, 1416-1419.
12. A. Ferst, Enzyme Structure and Mechanism, W. H. Freeman and Company, New York, 1999, pp. 245-272.
13. T. M. Tarasow, S. L. Tarasow, B. E. Eaton, J. Am. Chem. Soc. 2000, 122, 1015-1021.
14. a) B. Seelig, A. Jäschke Chem. Biol. 1999, 6, 167-176;
15. b) F. Stuhlmann, A. Jäschke J. Am. Chem. Soc. 2002, 124, 3238-3244.
16. a) K. Sakthivel, C. F. Barbas, Angew. Chem. 1998, 110, 2998-3002; Angew. Chem. Int. Ed. 1998, 37, 2872-2875;
17. a) K. Sakthivel, C. F. Barbas, Angew. Chem. 1998, 110, 2998-3002; Angew. Chem. Int. Ed. 1998, 37, 2872-2875;
18. b) S. A. Benner, T. R. Battersby, B. Eschgfaller, D. Hutter, J. T. Kodra, S. Lutz, T. Arslan, D. K. Baschlin, M. Blattler, M. Egli, C. Hammer, H. A. Held, J. Horlacher, Z. Huang, B. Hyrup, T. F. Jenny, S. C. Jurczyk, M. Konig, U. von Krosigk, M. J. Lutz, L. J. MacPherson, S. E. Moroney, E. Muller, K. P. Nambiar, J. A. Piccirilli, C. Y. Switzer, J. J. Vogel, C. Richert, A. L. Roughton, J. Schmidt, K. C. Schneider, J. Stackhouse, Pure Appl. Chem. 1998, 70, 263-266;
19. c) N. K. Vaish, A. W. Fraley, J. W. Szostak, L. W. McLaughlin, Nucleic Acids Res. 2000, 28, 3316-3322;
20. d) J. Matulic-Adamic, A. T. Daniher, A. Karpeisky, P. Haeberli, D. Sweedler, L. Beigelman, Bioorg. Med. Chem. Lett. 2000, 10, 1299-1302;
21. e) T. Gourlain, A. Sidorov, N. Mignet, S. J. Thorpe, S. E. Lee, J. A. Grasby, D. Williams, Nucleic Acids Res. 2001, 29, 1898-1905;
22. f) D. M. Perrin, T. Garestier, C. J. Helene, J. Am. Chem. Soc. 2001, 123, 1556-1563;
23. g) S. Lutz, P. Burgstaller, S. A. Benner, Nucleic Acids Res. 1999, 27, 2792-2798;
24. h) N. Teramoto, Y. Imanishi, Y. Ito, Bioconjugate Chem. 2000, 11, 744-748;
25. i) O. Thum, S. Jager, M. Famulok, Angew. Chem. 2001, 113, 4112-4115; Angew. Chem. Int. Ed. 2001, 40, 3990-3993.
26. i) O. Thum, S. Jager, M. Famulok, Angew. Chem. 2001, 113, 4112-4115; Angew. Chem. Int. Ed. 2001, 40, 3990-3993.
27. T. W. Wiegand, R. C. Janssen, B. E. Eaton, Chem. Biol. 1997, 4, 675-683.
28. B. Zhang, T. R. Cech, Chem. Biol. 1998, 5, 539-553.
29. G. P. Anderson, K. Shinagawa, Curr. Opin. Anti-Inflammatory Immunomodulatory Invest. Drugs 1999, 1, 29-38.
30. K. A. Davis, B. Abrams, L. Lin, S. D. Jayasena, Nucleic Acids Res. 1996, 24, 702-707.
31. a) T. M. Dewey, C. Zyzniewski, B. E. Eaton, Nucleosides Nucleotides 1996, 15, 1611-1617;
32. b) T. M. Tarasow, B. E. Eaton, Biopolymers 1998, 48, 29-37.
33. A tripeptide-phenylphosphonate similar in structure is known to be an irreversible elastase inhibitor: J. Oleksyszyn, J. C. Powers, Biochemistry 1991, 30, 485-493.
34. M. Illangasekare, G. Sanchez, T. Nickel, M. Yarus, Science 1995, 267, 643-647, and references [8, 9] herein.
35. T. M. Tarasow, T. S. Tarasow, B. E. Eaton, Nature 1997, 389, 54-56.
36. See the Supporting Information.
37. A. B. Burgin, C. Gonzalez, J. Matulic-Adamic, A.M. Karpeisky, N. Usman, J. A. McSwiggen, L. Beigelman, Biochemistry 1996, 35, 14090-14097.
38. a) M. P. Robertson, S. L. Miller, Science 1996, 268, 702-705;
39. b) M. Levy, S. L. Miller, J. Mol. Evolution 1999, 48, 631-637;
40. c) V. M. Kolb, J. P. Dworkin, S. L. Miller, J. Mol. Evol. 1994, 38, 549-557.
41. T. Fitzwater, B. Polisky, Methods Enzymol. 1996, 267, 295-299.
42. a) T. N. M. Schumacher, L. M. Mayr, D. L. MinorJr., M. A. Milhollen, M. W. Burgess, P. S. Kim Science 1996, 271, 1854-1857;
43. b) A. Nolte, S. Klußmann, R. Bald, V. A. Erdmann, J. P. Fürste, Nat. Biotechnol. 1996, 14, 1116-1119.